BioGeneration VenturesINVESTING IN THE NEXT GENERATION OF BIOTECH COMPANIES
BioGeneration Ventures manages funds that are actively investing venture capital in the next generation of successful Biotech companies in Europe with a focus on The Netherlands,
We focus on high potential companies active in therapeutics, medical devices, and diagnostics. The team of BioGeneration Ventures has a successful track record and a broad experience in the life sciences sector. Our involvement goes beyond only a financial investment. Having worked in startup and industry leaders ourselves our strategy is to generate value by working very closely with our portfolio companies and provide active hands-on support.
BioGeneration Ventures launched its first fund in 2006 and its second fund in 2012 both backed by a broad international and strategic investor base. We have achieved several exits and a very strong fund performance. Following the exceptional exit results from our investments in
Early stage venture investments
250K – 2,5M
Biotechnology, life Sciences
Acerta Pharma, Arcarios, arGEN-X, BioCeros, Cristal Therapeutics, Dezima Pharma, EPD-vision, FlexGen, Lathio Pharma, Medisse, Mucosis, NovioGendix, Progentic Orthobiology, SurgVision, Synaffix